Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Gross Margin (2016 - 2026)

Avanos Medical's Gross Margin history spans 13 years, with the latest figure at 47.54% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 703.0% to 47.54% in Q4 2025 year-over-year; TTM through Dec 2025 was 50.47%, a 497.0% decrease, with the full-year FY2025 number at 50.47%, down 497.0% from a year prior.
  • Gross Margin hit 47.54% in Q4 2025 for Avanos Medical, down from 48.37% in the prior quarter.
  • Over the last five years, Gross Margin for AVNS hit a ceiling of 90.22% in Q4 2021 and a floor of 45.98% in Q2 2021.
  • Historically, Gross Margin has averaged 55.68% across 5 years, with a median of 54.69% in 2024.
  • Biggest five-year swings in Gross Margin: soared 4347bps in 2021 and later plummeted -3356bps in 2022.
  • Tracing AVNS's Gross Margin over 5 years: stood at 90.22% in 2021, then crashed by -37bps to 56.66% in 2022, then dropped by -3bps to 54.82% in 2023, then decreased by 0bps to 54.57% in 2024, then decreased by -13bps to 47.54% in 2025.
  • Business Quant data shows Gross Margin for AVNS at 47.54% in Q4 2025, 48.37% in Q3 2025, and 52.63% in Q2 2025.